Application YC di Cambridge Cancer Genomics

Summer 2017Inactive

Cambridge Cancer Genomics ha partecipato a Y Combinator nel batch Summer 2017 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Summer 2017
Settore: HealthcareDiagnostics
Dimensione team: 25
Stato: Inactive
Lanciata: 2017

Founder

John CassidyFounder/CEO
Nirmesh PatelFounder/Chief Scientific Officer
Evaline TsaiFounder/CPO

Cosa fa Cambridge Cancer Genomics

CCG.ai exist to ensure that each patient has the right drug, at the right time, to beat their cancer. ‍ We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance. We are expanding our team in Cambridge, UK, offering a fantastic opportunity for dedicated individuals who are comfortable in a high-work high-reward environment, and who are enthusiastic for a dynamic and varied role. We are looking for people who fit well into our team and company culture, and who like to overcome challenges and drive the business forward. In exchange, we offer a competitive salary with performance related bonuses and stock options, alongside excellent career development opportunities in a fast-growing start-up with a chance to truly impact how cancer is treated. To apply, please send your CV to

Application YC di Cambridge Cancer Genomics, ricostruita

Domanda per Y Combinator

Cambridge Cancer Genomics, batch Summer 2017. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Cambridge Cancer Genomics

Describe what your company does in 50 characters or less.

Personalized cancer treatment planning software

What is your company going to make? Please describe your product and what it does or will do.

We build software that helps oncologists interpret clinical and genomic data to pick the right drug for each cancer patient. Our platform analyzes patient biomarkers and treatment responses to guide precision oncology decisions.

Where do you live now, and where would the company be based after YC?

We currently live and work in Cambridge, England, United Kingdom, and the company remains based there.

Explain your decision regarding location.

Cambridge has the scientific and clinical expertise in genomics and oncology we need. Being close to hospitals and research centers allows faster collaboration and product validation.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Cambridge Cancer Genomics?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Cambridge Cancer Genomics (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Cambridge Cancer Genomics si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva Cambridge Cancer Genomics?

Cambridge Cancer Genomics apparteneva al batch Summer 2017 di Y Combinator.

Chi ha fondato Cambridge Cancer Genomics?

Cambridge Cancer Genomics è stato fondato da John Cassidy, Nirmesh Patel, Evaline Tsai.

Cosa fa Cambridge Cancer Genomics?

CCG.ai empowers clinicians to make personalised treatment strategies…

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Cambridge Cancer Genomics, e di ogni altro batch YC, è in YC Insights.